Yahoo
NasdaqCM - Delayed Quote USD

CollPlant Biotechnologies Ltd. (CLGN)

3.9700 +0.0300 (+0.76%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
318
2,371
515
10,959
299
Cost of Revenue
1,341
835
1,625
1,991
400
Gross Profit
-1,023
1,536
-1,110
8,968
-101
Operating Expense
11,382
13,019
16,141
16,480
16,996
Operating Income
-12,405
-11,483
-17,251
-7,512
-17,097
Net Non Operating Interest Income Expense
263
365
721
778
287
Other Income Expense
--
-371
-79
-285
-115
Pretax Income
-12,513
-11,489
-16,609
-7,019
-16,925
Net Income Common Stockholders
-12,513
-11,489
-16,609
-7,019
-16,925
Diluted NI Available to Com Stockholders
-12,513
-11,489
-16,609
-7,019
-16,925
Basic EPS
-9.50
-9.40
-14.50
-6.20
-15.30
Diluted EPS
-9.50
-9.40
-14.50
-6.20
-15.30
Basic Average Shares
1,232.5360
1,220.3260
1,145.4180
1,138.9160
1,103.3310
Diluted Average Shares
1,232.5360
1,220.3260
1,145.4180
1,138.9160
1,103.3310
Total Operating Income as Reported
-12,405
-11,483
-17,251
-7,512
-17,097
Total Expenses
12,723
13,854
17,766
18,471
17,396
Net Income from Continuing & Discontinued Operation
-12,513
-11,489
-16,609
-7,019
-16,925
Normalized Income
-12,142
-11,118
-16,530
-6,734
-16,810
Interest Income
--
380
738
788
321
Net Interest Income
263
365
721
778
287
EBIT
-12,405
-11,483
-17,251
-7,512
-17,097
EBITDA
-11,559
-10,571
-16,213
-6,410
-16,021
Reconciled Cost of Revenue
1,341
835
1,625
1,991
400
Reconciled Depreciation
846
912
1,038
1,102
1,076
Net Income from Continuing Operation Net Minority Interest
-12,513
-11,489
-16,609
-7,019
-16,925
Total Unusual Items Excluding Goodwill
-371
-371
-79
-285
-115
Total Unusual Items
-371
-371
-79
-285
-115
Normalized EBITDA
-11,188
-10,200
-16,134
-6,125
-15,906
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 1/31/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: